Sunshine Biopharma Inc.Sunshine Biopharma Inc.Sunshine Biopharma Inc.

Sunshine Biopharma Inc.

No trades
No trades

Fundamentals and stats

EPS and revenue snapshot

In the last quarter, the company reported −2.50 USD per share, beating the −2.50 USD estimate by 0.00%. Revenue for the same period reached ‪8.09 M‬ USD, despite the estimate of ‪8.09 M‬ USD. For the next quarter, analysts expect −1.20 USD in earnings per share and ‪8.70 M‬ USD in revenue.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise